Videos
Industry-Sponsored Lecture (Biocare)
MOXI-Why? An overview of Moxifloxacin in Clinical Practice
Speaker: Manohar Lal Gupta, MD
Videos
Industry-Sponsored Lecture (Pfizer)
How can we Integrate New Antibiotics and Antimicrobial Stewardship for the Future?
Speaker: Francesco Giuseppe De Rosa, MD
Videos
Industry-Sponsored Lecture (Biomerieux)
F.A.S.T: BioFire Assays for Swift & Targeted Treatment – Rapid Multiplex PCR Tests for Infectious Diseases
Speaker: Marion Priscilla A. Kwek, MD, FPCP, FPSMID
Videos
Industry-Sponsored Lecture (MSD)
Critical Decisions for Critical Patients: Management on Nosocomial Pneumonia in an Era of MDRO
Speakers:
Marin Hristo Kollef, MD, FACP, FCCP
Rontgene M. Solante, MD, FPCP, FPSMID
Videos
Industry-Sponsored Lecture (Sandoz)
TB+HIV Updates
Speakers:
Daniel Tan, MD, FPCP
Rontgene M. Solante, MD, FPCP, FPSMID
Videos
Industry-Sponsored Lecture (Philcare Pharma)
High-Dose (HD) Tigecycline Therapy: A Potent carbapenem-sparing weapon against MDROs (CRE/A. bau)
Speaker: Adrian Joseph L. Buensalido, MD, FPCP, FPSMID
Moderator: Jemelyn U. Garcia, MD, FPC, FPSMID
Videos
Industry-Sponsored Lecture (Mylan)
Cardiac, Renal & Pulmonary complications in COVID-19 patients; expert experience in managing/recovery
Speakers:
Rontgene M. Solante, MD, FPCP, FPSMID
Aileen Wang, MD, FPCP, FPCCP
Videos
Industry-Sponsored Lecture (GSK)
COVID and AMR: Antibiotic Use During COVID-19 Pandemic and Implication for the Future
Speaker: Adrian Lijavetzki, MD
Videos
Industry-Sponsored Lecture (Camber)
Clinical Advances in the management of HIV guidelines and New Evidence
Speaker: Joseph Perriëns, MD, PhD
University of Ghent, Belgium
Videos
Industry-Sponsored Lecture (Roche)
Understanding COVID-19: Testing and Optimizing Testing Strategies
Speaker: Aw Tar Choon, MD
The Philippine Society for Microbiology and Infectious Diseases (PSMID) Guidance on the Management of Mpox, Ver. 1 provides the basic and most updated information on management of patients confirmed with mpox.
This guidance complements the mpox recommendations of the DOH (Updated Interim Guidelines on the Prevention, Detection, and Management of MPOX, by Department of Health, August 26, 2024, Department Memorandum 2024-0306) and PHICS-PHICNA (Interim Guidelines on the Prevention and Control of Monkeypox version 1).
The antivirals, immunoglobulin and vaccines discussed below are not available locally. In our local situation, we should maximize supportive care for mpox cases.